Feature Channels: Pharmaceuticals

Filters close
Released: 6-Apr-2020 3:35 PM EDT
BIDMC launches clinical trial to assess common anti-clotting medication for treatment of COVID-19-related respiratory failure
Beth Israel Deaconess Medical Center

A team of physician-scientists at Beth Israel Deaconess Medical Center are now enrolling patients in a clinical trial to evaluate a common anti-clotting drug for the treatment of COVID-19-positive patients with ARDS. The newly launched trial follows a special report the team published in the Journal of Trauma and Acute Care Surgery that suggested the use of a drug called tPA could reduce deaths among patients with ARDS as a complication of COVID-19.

Released: 6-Apr-2020 11:05 AM EDT
Rush Testing Remdesivir as a Potential Treatment for COVID-19
Rush University Medical Center

Rush University Medical Center is participating in a new clinical trial to test the effectiveness of the drug remdesivir in the treatment of coronavirus disease 2019 (COVID-19).

Newswise: Penn Launches Trial to Evaluate Hydroxychloroquine to Treat, Prevent COVID-19
Released: 6-Apr-2020 9:00 AM EDT
Penn Launches Trial to Evaluate Hydroxychloroquine to Treat, Prevent COVID-19
Perelman School of Medicine at the University of Pennsylvania

A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the drug hydroxychloroquine (HCQ) can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether

Newswise: UCLA clinical trial tests anti-viral drug remdesivir and other therapies against COVID-19
Released: 3-Apr-2020 4:25 PM EDT
UCLA clinical trial tests anti-viral drug remdesivir and other therapies against COVID-19
University of California, Los Angeles (UCLA), Health Sciences

UCLA Health is one of 75 sites around the globe participating in a clinical trial sponsored by the National Institutes of Health to test the effectiveness of a candidate anti-viral drug against COVID-19.

Newswise: 228393_web.jpg
Released: 3-Apr-2020 2:25 PM EDT
Trial drug can significantly block early stages of COVID-19 in engineered human tissues
University of British Columbia

An international team led by University of British Columbia researcher Dr. Josef Penninger has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.

Newswise: Rutgers Cancer Institute Offers Clinical Trial Examining Potential Treatment for COVID-19
Released: 3-Apr-2020 1:35 PM EDT
Rutgers Cancer Institute Offers Clinical Trial Examining Potential Treatment for COVID-19
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey, a National Cancer Institute-designated Comprehensive Cancer Center, is offering a clinical trial as a potential treatment for patients diagnosed with the coronavirus (COVID-19). The trial, which is not limited to cancer patients is exploring hydroxychloroquine and azithromycin.

Released: 3-Apr-2020 12:45 PM EDT
Trial for Potential Coronavirus Treatment is Underway at Montefiore and Einstein
Albert Einstein College of Medicine

Montefiore Health System and Albert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection.

Released: 3-Apr-2020 9:40 AM EDT
Harrington Discovery Institute at University Hospitals to Aid in Global Fight Against Coronavirus Pandemic
University Hospitals Cleveland Medical Center

Announcement from the Harrington Discovery Institute at University Hospitals of a new initiative that galvanizes its transatlantic network of academic institutions, foundations, and philanthropic partners to accelerate promising, near-term therapies to treat COVID-19 and its complications and battle future pandemic threats. In advancing its portfolio of 120 drugs-in-the-making at 54 leading academic centers in North America and the U.K., HDI has developed a proven model that has enabled scientists in academia to accelerate their breakthrough drug discoveries toward trials in patients.

Newswise:Video Embedded media-invited-to-ask-questions-covid-19-testing-drug-discovery-infectiousness-and-more-press-conference-april-2-2020
VIDEO
Released: 3-Apr-2020 9:00 AM EDT
TRANSCRIPT AND VIDEO AVAILABLE: Media Invited to Ask Questions - COVID-19 Testing, Drug Discovery, Infectiousness, and more: Press Conference April 2, 2020
Newswise

Media are invited to attend and ask questions at this Virtual Press Conference with a Newswise Live Expert Panel to discuss the COVID-19 crisis.


Showing results

110 of 10

close
2.22851